State of Alaska Department of Revenue’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
11,115
-565
| -5% | -$71K | 0.01% | 874 |
|
|
2025
Q1 | $1.29M | Buy |
11,680
+145
| +1% | +$16K | 0.01% | 881 |
|
|
2024
Q4 | $1.57M | Sell |
11,535
-200
| -2% | -$27.3K | 0.02% | 825 |
|
|
2024
Q3 | $1.35M | Buy |
11,735
+795
| +7% | +$91.6K | 0.01% | 910 |
|
|
2024
Q2 | $1.51M | Buy |
10,940
+145
| +1% | +$20K | 0.02% | 793 |
|
|
2024
Q1 | $1.49M | Buy |
10,795
+185
| +2% | +$25.5K | 0.02% | 831 |
|
|
2023
Q4 | $1.4M | Sell |
10,610
-995
| -9% | -$131K | 0.02% | 837 |
|
|
2023
Q3 | $1.31M | Sell |
11,605
-490
| -4% | -$55.1K | 0.02% | 816 |
|
|
2023
Q2 | $1.14M | Sell |
12,095
-1,214
| -9% | -$114K | 0.01% | 906 |
|
|
2023
Q1 | $1.35M | Sell |
13,309
-147
| -1% | -$14.9K | 0.02% | 831 |
|
|
2022
Q4 | $1.61M | Buy |
13,456
+185
| +1% | +$22.1K | 0.02% | 730 |
|
|
2022
Q3 | $1.41M | Sell |
13,271
-460
| -3% | -$48.8K | 0.02% | 762 |
|
|
2022
Q2 | $1.34M | Buy |
13,731
+385
| +3% | +$37.5K | 0.02% | 803 |
|
|
2022
Q1 | $1.25M | Sell |
13,346
-385
| -3% | -$36.1K | 0.01% | 888 |
|
|
2021
Q4 | $1.17M | Sell |
13,731
-795
| -5% | -$67.7K | 0.01% | 1000 |
|
|
2021
Q3 | $1.39M | Sell |
14,526
-157
| -1% | -$15.1K | 0.01% | 900 |
|
|
2021
Q2 | $1.43M | Sell |
14,683
-45,517
| -76% | -$4.43M | 0.01% | 894 |
|
|
2021
Q1 | $5.85M | Buy |
60,200
+9,444
| +19% | +$918K | 0.06% | 341 |
|
|
2020
Q4 | $4.86M | Sell |
50,756
-8,184
| -14% | -$784K | 0.06% | 366 |
|
|
2020
Q3 | $5.67M | Buy |
58,940
+385
| +0.7% | +$37K | 0.07% | 315 |
|
|
2020
Q2 | $7.14M | Buy |
+58,555
| New | +$7.14M | 0.09% | 294 |
|
|
2019
Q3 | – | Sell |
-10,532
| Closed | -$889K | – | 1712 |
|
|
2019
Q2 | $889K | Buy |
10,532
+30
| +0.3% | +$2.53K | 0.01% | 796 |
|
|
2019
Q1 | $925K | Sell |
10,502
-493
| -4% | -$43.4K | 0.02% | 755 |
|
|
2018
Q4 | $785K | Buy |
10,995
+80
| +0.7% | +$5.71K | 0.02% | 752 |
|
|
2018
Q3 | $1.34M | Buy |
10,915
+115
| +1% | +$14.1K | 0.02% | 635 |
|
|
2018
Q2 | $1.06M | Buy |
10,800
+2,630
| +32% | +$258K | 0.02% | 686 |
|
|
2018
Q1 | $677K | Buy |
8,170
+1,770
| +28% | +$147K | 0.01% | 805 |
|
|
2017
Q4 | $496K | Buy |
+6,400
| New | +$496K | 0.01% | 807 |
|